Rapid titration versus conventional titration of quetiapine in the treatment of bipolar mania: A preliminary trial

International Clinical Psychopharmacology

Volumn 20, Issue 6, 2005, Pages 327-330

  Pae, Chi Un ^a,c   Ghaemi, S Nassir ^b   Kim, Tae Suk ^a   Kim, Jung Jin ^a   Lee, Soo Jung ^a   Lee, Chang Uk ^a   Lee, Chul ^a   Paik, In Ho ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c The Catholic University of Korea   (South Korea)

Author keywords

Bipolar mania; Conventional titration; Quetiapine; Rapid titration

Indexed keywords

MOOD STABILIZER; QUETIAPINE;

ADULT; AKATHISIA; ARTICLE; BIPOLAR MANIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION; SIDE EFFECT; TITRIMETRY; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 26944493375     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200511000-00008     Document Type: Article

References (13)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC: American Psychiatric Association.
2. Baker RW, Kinon BJ, Maguire GA, Liu H, Hill AL (2003). Effectiveness of rapid initial dose escalation of up to 40 milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol 23:342-348.
3. Barnes TR (1989). A rating scale for drug-induced akathisia. Br J Psychiatry 154:672-676.
4. Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J (2003a). A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clin Ther 25:530-541.
5. Chengappa KN, Parepally H, Brar JS, Mullen J, Shilling A, Goldstein JM (2003b). A random-assignment, double-blind, clinical trial of once- versus twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study. Can J Psychiatry 48: 187-194.
6. Correll CU, Leucht S, Kane JM (2004). Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161:414-425.
7. DeVane CL, Nemeroff CB (2001). Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet 40:509-522.
8. Emsley RA, Raniwalla J, Bailey PJ, Jones AM (2000). A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional anti-psychotic treatment. PRIZE Study Group. Int Clin Psychopharmacol 15: 121-131.
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured Clinical Interview for DSM-IV-Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press.
10. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology. Publication (ADM) 223-244. Washington, DC: US Department of Health, Education, and Welfare Government Printing Office.
11. Sachs G, Chengappa KN, Suppes T, Mullen JA, Brecher M, Devine NA, et al. (2004). Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 6:213-223.
12. Simpson GM, Angus JW (1970). A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212 (suppl):S11-S19.
13. Young RC, Biggs JT, Ziegler VE, Meyer DA (1978). A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429-435.